We believe the future of preventive care starts with empowering individual health ownership.
We research and develop cancer screening tools for early detection utilizing the untapped power of tears.
We are a CLIA Certified High Complexity Clinical Lab and Research & Development Lab working together to develop and validate tools for accurate and accessible cancer screening.
Research & Development
Constantly exploring new methods and technologies to improve the accuracy and accessibility of our screening tests.
Our CLIA certification gives our patients and healthcare providers confidence in the quality of our screening tests.
Our laboratories allow us to perform complex tests, including those used in cancer screening, with a high degree of accuracy and precision.
Our laboratory is equipped with state-of-the-art facilities and equipment to support our research and development efforts.
Founder & CEO
Omid Moghadam is the founder and CEO of Namida Lab. He is an inventor, entrepreneur, venture investor, and educator. He specializes in launching new ventures with social impact in health and technology. Moghadam has inventions in medical imaging, cryptography, microprocessor design, medical devices, diagnostics, digital photography, data science, and communications. He is currently the Chairman of RAPID Dosimetry, a precision medicine company he also co-founded and a board member of The Diary Corporation.
He is the past founder or co-founder of nine companies in Healthcare IT, genomics, diagnostics, and medical imaging, and has held executive positions at Intel, Eastman Kodak, and CTG-AMS Corporations.
He formerly served on the advisory boards of Robert Wood Johnson Foundation, Children's Hospital Boston, and California Healthcare Foundation, and has held academic positions at Harvard Medical School Department of Biomedical Informatics, Rensselaer Polytechnic Institute Lally School of Business as well as an EIR position at UCLA.
Mr. Moghadam’s past approaches to innovation have been highlighted in two books: Grabbing Lightning, and The Innovators Prescription. Omid loves art, history, languages, and travel. Most Sundays he can be found sweating over FT’s Polymath crossword puzzle.
Anna Daily, Ph.D
Chief Scientific Officer
Anna Daily, Ph.D
Anna Daily, Ph.D., is the Chief Scientific Officer at Namida Lab where she works to establish clinical, industrial, and academic partnerships both locally and across the country. Anna is the inventor of Auria, the first at-home tear-based breast health assessment test. She has had the opportunity to present on the research and science behind Auria both nationally and internationally. In 2015, Anna was selected to present as a national finalist in the InnovateHer business competition in Washington D.C. In 2016, she collaborated with international ad agency DDB, located in New Zealand, to develop a national breast cancer awareness campaign.
Dr. Daily received her Ph.D. in Cellular and Molecular Biology from the University of Arkansas and provides expertise in the expression and purification of recombinant proteins, genetic engineering/cloning, as well as numerous biophysical and analytical chemistry techniques towards the characterization of proteins. She is an Arkansas native and lives in Fayetteville with her husband and son.
Laboratory Medical Director
Lucas Campbell has held several Medical Directorships of CLIA and CAP-certified clinical laboratories. He is a practicing pathologist, serving as CEO/COO of Northwest Arkansas Pathology Associates. He has led improvement projects during his career, leveraging customizable information technology systems to improve efficiency and decrease cost. Campbell holds an MD from and fellowships at the University of Chicago and Washington University-St. Louis.
He is a lifelong Arkansan and lives in Fayetteville with his wife, Dr. Jenny Campbell, and their two girls. He enjoys fishing and family time on the lake.
Vice President of Operations
Jen Morio is the Vice President of Operations for Namida Lab, Inc. She leads the corporate operational activities and designs, executes, and manages Namida’s initiatives to ensure all business functions are in line with the strategic goals.
Her career has been spent in the startup world, spanning over 15+ years. Prior to Namida, she worked with NOWDiagnostics Inc., a leader in innovative diagnostics testing. Her experience includes sales in point-of-care medical devices, business operations, investor relations, and working closely with all departments along with entrepreneurs and business and technology experts to organize operations and procedures.
She also has experience in ground level start up from her time at VIC Technology Venture Development, a development firm that grows young companies that own innovative technology with significant commercial potential, to provide the companies with senior management experience, knowledge of technology company start-up, and proven processes to execute business strategies.
Kelsey Kirchner is the General Supervisor for Namida Lab, Inc. She oversees all aspects of the laboratory operation and personnel performing testing. In addition, she is also a clinical laboratory scientist, bringing over 7 years of expertise in high-quality clinical laboratory experience. She has professionally performed complex tests, quality control, training, reporting, and validations under strict guidelines of laboratory policies, procedures, GMP, FDA, CAP, ISO, and OSHA. She has personally operated over 20 lab instruments and has excessive knowledge of sterile technique, chemical, biological and mathematical principles.
Before joining Namida, she has held positions with numerous fortune 500 companies, including the second-largest food production company in the world as a Microbiologist IV, identifying and isolating microorganisms using differential testing and aseptic technique in addition to carrying out bacterial identification using VITEK and confirmation using PCR method testing using BAX, BioRad, VIDAS, and Roka Atlas System. She has experience in quality assurance and is resilient and proactive in developing new processes, improving documentation and techniques to enhance laboratory function and overall quality practices.
She holds a Bachelor’s of Science in Microbiology and Immunology from Colorado State University and is currently pursuing a master’s degree in public health.
Prashanth Ravishankar, Ph.D.
Research & Development Scientist
Prashanth Ravishankar, Ph.D.
Prashanth Ravishankar, Ph.D., is a R&D Scientist at Namida Lab. He brings over 8 years of expertise in high-quality research laboratory and engineering experience to the Namida team. He has served as a technical consultant for start-up companies both locally and internationally, assisting in experimental design, grant writing, custom prototype design, and mentorship. Prashanth’s expertise spans the scientific gamut from molecular biology to biomaterial fabrication. As a result, he has acquired extensive knowledge in chemical and biological principles, aseptic technique, and has operated over 25 lab instruments across disciplines. As an R&D Scientist, Prashanth plays an integral role in the advancement of technologies from lab bench to product.
Prashanth has a doctorate in Biomedical Engineering as well as a Masters's in Operations Management from the University of Arkansas. He received his Bachelor of Technology in Biotechnology from SRM University, India. He is invested in technology, world history, travel, and loves to solve sequential puzzles.
Ashton Leehans is a Laboratory Technician at Namida Lab, Inc. where he assists in clinical testing and analysis, as well as maintaining quality control and calibration of all laboratory equipment to ensure testing accuracy. He brings over 4 years of high-quality clinical laboratory experience and is proficient in performing high complexity genetic testing in accordance with guidelines from CAP, CLIA, and ISO.
Before joining Namida Lab, he worked as a Microbiologist with the Arkansas Public Health Laboratory for the Arkansas Department of Health where his primary responsibility was screening newborns for genetic diseases. In addition, he performed PCR and ELISA-based clinical tests and established new laboratory methods to maximize efficiency.
Here at Namida Lab, Ashton works closely with the Technical Supervisor to ensure the execution of regulatory procedures and adherence to clinical laboratory guidelines meet the highest quality standards.
He holds a Bachelor of the Arts in Biology from the University of Arkansas. He is an Arkansas native and lives in Bentonville with his Fiancé.
Chief Medical Officer
Dr. Brigitte Piniewski is the Interim Chief Medical Officer at Namida Lab. She is a rare balance of medical, technical and innovation expertise, with a talent for explaining complex topics in ways that help others see why they matter. After several years as a primary care physician with obstetrics, she became Chief Medical Officer for one of the largest reference laboratories in the Pacific Northwest. Here she led collaborations with Universities, Technology Alliances and Innovators using digital tools to advance population health. Currently, Dr. Piniewski provides subject matter expertise for investor diligence as well as for health tech startups leveraging blockchain and web3-based solutions. Wealthcare: Demystifying Web3 and the rise of personal data economies, is her first book and will be available early 2023.
Dr Piniewski earned her medical degree from the University of British Columbia, Vancouver, B.C. and completed her internship at McGill University, Montreal, Quebec, Canada. She is currently based in Portland, Oregon.
Manager of Customer Service
Amber Alsbury is the Manager of Customer Service for Namida Lab. She manages buyer relationships, improves customer service experience, and supports sales opportunities. She holds thorough knowledge of GCP, HIPPA, and relevant regulations for the conduct of clinical trial support at Namida Lab. In addition, she is responsible for a broad set of tasks to provide the fundamental framework to secure proficiency and compliance to ensure all team members have adequate support to work efficiently. She manages all clerical and administrative tasks in addition to cross-functional duties that are vital for the productivity of the company. Her professional experience has been dedicated to the health industry. She is BLS certified and a licensed phlebotomist. She spent several years working for a comprehensive cancer care group focused on patient care, education, patient support groups, and research through clinical trials. She previously worked as a Laboratory Support Technician I for one of the largest U.S. health systems, with 44 acute care & specialty hospitals, and over 700 physician & outpatient clinics throughout the USA. She also dedicated time to Counseling & Psychological Services as an Administrative Specialist III. In addition, she also has business experience managing communication procedures, guidelines, and policies for an online marketing and merchandising platform that operated a portfolio of e-commerce sites. Amber holds a Bachelor of Science in Family and Consumer Sciences in addition to numerous health licenses and training. She is an Arkansas native and lives in Fayetteville with her daughter.
Suzanne Klimberg, MD, MSHCT, PhD, FACS
Clinical Advisory Board
Suzanne Klimberg, MD, MSHCT, PhD, FACS
Dr. V. Suzanne Klimberg has 30 years of experience in breast surgical oncology. She has pioneered innovative breast cancer treatment methods of patients, authored over 350 publications in peer-reviewed journals, 15 books, and has held over 25 editorial board positions for surgical journals and publications. Additionally, Dr. Klimberg has won over 75 awards in teaching, research, and clinical care, and is the past president of three major American surgical organizations and Treasurer of another. She is a Senior Director for the American Board of Surgery, the American Board of Plastic Surgery and the American Board of Complex Surgical Oncology. She is Chair of the Oncoplastic Breast Skills Course at the American College of Cancer. She is and has been funded by the NIH, American Cancer Society, Merit Review, and the Fashion Footwear Association of New York. She has held the Muriel Balsam Kohn Chair in Breast Surgical Oncology, and was presented with her own named lectureship by her colleagues and friends at UAMS.
Steven Harms, MD, FACR, Emeritus
Clinical Advisory Board
Steven Harms, MD, FACR, Emeritus
Dr. Steven E. Harms has recently retired as a breast imaging specialist with The Breast Center. He is recognized nationally in the area of magnetic resonance imaging (MRI), specifically Breast MRI, and was named “Komen Foundation Scientist of the Year” by Susan G. Komen for the Cure in 1998. In 1995, he was given the annual William Beaumont Award by the American Medical Association for the outstanding physician in the nation under the age of 50. He was formerly on the faculty at the University of Arkansas for Medical Sciences (UAMS), Baylor University Medical Center, and M. D. Anderson Cancer Institute. During his 14 years as director of MRI at Baylor, Dr. Harms and his research team developed MRI applications including RODEO Breast MRI. He helped draft the 2007 American Cancer Society breast cancer screening guidelines that recommend breast MRI screening for high risk patients. He served as member and chairman of the Radiologic Devices Panel for the US Food and Drug Administration from 1983-2001. Harms is a fellow of the Society of Breast Imaging, a fellow of the American College of Radiology, and has been on the Best Doctors in America since 2003. Harms practiced at MANA’s The Breast Center in Fayetteville, Arkansas since 2004 and continues to be a clinical professor at UAMS.
Dr. Harms has authored over 116 scientific papers, 43 book chapters, and 11 patents. He is past-president of the International Society of Magnetic Resonance in Medicine. Dr. Harms was previously on the board of directors and program chair for the American Society of Breast Disease and the Society of Magnetic Resonance in Medicine. Dr. Harms served on the American College of Radiology Breast MRI Lexicon Committee and the Susan G. Komen Public Policy Committee. He was previously associate editior of the Journal of Magnetic Resonance Imaging and The Breast Journal. He has been a visiting professor at medical schools throughout the world including Harvard, Johns Hopkins, Northwestern, Stanford, Yale, Peking Medical University, Taipei Medical University, and University College London.
Michael is the Sr. Director of Integrated Marketing at Simmons Pet Food in Siloam Springs, AR. He joined Simmons in 2021 and has enjoyed a 30 year career in a variety of sales and marketing roles, with an emphasis the last 10 years in Shopper Marketing and Innovation. Michael graduated from Oklahoma Christian University with a Bachelor of Science degree in Marketing.
Michael volunteers with local school booster organizations and has previously served on the NWA board of the American Red Cross. He and his family are active members of the Bentonville church of Christ.
Marcus Osborne is the CEO of RightMove, a nationwide provider of virtual musculoskeletal physical therapy. Prior to earning his MBA at Harvard in 2007, Osborne completed an internship at The White House and served as CFO of the Clinton Foundation's HIV/AIDS Initiative. Osborne played a key role in Walmart's push into healthcare as SVP of Walmart Health.
Board of Directors
Todd Simmons is the Chief Executive Officer of Simmons Foods, Inc. and Affiliates located in Siloam Springs, AR. He joined Simmons in 1990. Todd attended Georgetown University where he earned a Bachelor of Science degree in Business Management and a Minor in Theology. Todd began his work at Simmons at the age of 19 and has trained in all areas of the business. He was promoted to Chief Executive Officer in 2012.
Todd is Chairman of the Board of Namida Lab Inc., and is a General Partner of Natural Capital LLC. He currently serves on the Boards of the National Chicken Council, Signature Bank of Arkansas, The Razorback Foundation, Theatre Squared, Northwest Arkansas Council and Endeavor Global of Northwest Arkansas.
Board of Directors
Rob Kimbel is an owner of Kimbel Mechanical Systems, Inc., located in Fayetteville, AR. He joined KMS in 1995, and in 2001, at the age of 26, he became a partner and grew what was then a small local plumbing company into a national company with 1200+ employees. Today, the company has operations in 20+ states across the country.
Rob is also a partner in multiple start-ups, real estate projects and real estate funds that specialize in affordable housing across the United States.
Rob is also a mentor and advisor to several local businesses and entrepreneurs in NW Arkansas. He has also served on the boards of Generations Bank, NWA Home Builders Association and Beyond the Game, a non-profit organization serving the impoverished of the Dominican Republic.
Board of Directors
Fryar is an Arkansas native who graduated from the University of Arkansas with degrees in economics and agricultural economics. Fryar earned a doctorate in agricultural and applied economics from the University of Minnesota. Fryar was a professor of agricultural economics at the University of Arkansas for 13 years. He has published articles in more than 50 professional journals, and he has 40 years of professional experience in agriculture.
Fryar co-founded Ozark Mountain Poultry, which specializes in raising chickens without antibiotics or animal by-products. According to the release, Fryar sold the company eight years later, and it employed 1,800 people with plants in Rogers, Batesville, Magness, Bay, and Newport. Fryar has been on the state Council of Economic Advisers for governors since 1983. He was a member of the Fayetteville School Board in the late 1980s and early 1990s. In 2010, he served as treasurer for Congressman Steve Womack's campaign for the U.S. House of Representatives. He is a member of the Agribusiness Council for the Federal Reserve Bank of St. Louis.
Board of Directors
Ran Whitehead, NMG Consultant, is a seasoned laboratory executive with more than 40 years of experience. Mr. Whitehead has led laboratories in a variety of settings from founding a start-up venture capital-backed laboratory in Tennessee to leading for-profit and non-for-profit laboratories in Florida, North Carolina, Tennessee, New Mexico, and Oregon.
Mr. Whitehead is an expert at strategic development, lab construction and site development, LIS implementation and outreach development. He is well known for his technical and clinical excellence, collaborative partnerships, and innovative programs. He has also led initiatives such as the distance learning program that was later adopted by laboratories across the country.
Prior to joining NMG, he most recently served as CEO at PeaceHealth Laboratories where he integrated twelve laboratory operations in to one operating unit with standardized policies, procedures and equipment. While there he also developed new service lines to enhance future revenues, introduced Lean Assessment program for process improvement and implemented the EPIC/Beaker LIS.
Mr. Whitehead also served as CEO at SED Medical Laboratories in Albuquerque, NM and Oregon Medical Laboratories in Eugene, OR. He has also held senior leadership positions at Lee Memorial Health System in Fort Myers, FL, Moses Cone Health System in Greensboro, NC and at Duke University Medical Center in Durham, NC. He has presented at the Executive War College, Frontiers in Laboratory Medicine, California Clinical Laboratory Association and Roche Molecular Center of Excellence. He has also led numerous online seminars and has authored several articles for the Medical Laboratory Observer and released four podcasts focusing on the clinical laboratory industry.
Mr. Whitehead served on the Boards at Lane Workforce Partnership, Lane Memorial Blood Bank, New Mexico Workforce Partnership and Ascendant Diagnostics.
He earned his Master of Business Administration at Duke University and his Bachelor of Science in Medical Technology at Michigan State University. Ran lives in Santa Barbara, CA with his wife.
Harnessing the Healing Power of Tears in the Fight Against Cancer
Our name, Namida, is derived from the Japanese word for tears, reflecting our focus on utilizing the power of tears to identify early-stage cancers. We use cutting-edge proteomics and genomics technologies to analyze the unique biomarkers present in tears, which can indicate the presence of cancer.
We’re a revenue stage biotech company with big ideas, and the science to make them happen.
Be a part of the future of cancer screening.
1905 E Mission Blvd. Suite 6 Fayetteville, AR 72703 479-334-2828